Stratification of recurrent differentiated thyroid cancer with elevated thyroglobulin and negative I-131 whole body scan by restaging 18F FDG PET/CT

被引:0
|
作者
Okuyucu, K. [1 ]
Ince, S. [1 ]
Alagoz, E. [1 ]
Emer, O. [1 ]
San, H. [1 ]
Balkan, E. [1 ]
Ayan, A. [1 ]
Gunalp, B. [1 ]
Karacalioglu, A. O. [1 ]
Arslan, N. [1 ]
机构
[1] Gulhane Training & Res Hosp, Dept Nucl Med, Ankara, Turkey
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0511
引用
收藏
页码:S649 / S650
页数:2
相关论文
共 50 条
  • [21] 18F-FDG-PET scans and high dose of iodine-131 (I-131) treatment in patients with elevated thyroglobulin and negative iodine-131 scan differentiated thyroid carcinoma
    McEwan, Alexander
    Ma, Chao
    Morrish, Donald
    McMullen, Todd
    Capelle, Lisa
    Severin, Diane
    Jha, Naresh
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [22] 18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I
    Pedro Weslley Rosario
    European Journal of Nuclear Medicine and Molecular Imaging, 2020, 47 : 2950 - 2951
  • [23] 18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with131I
    Rosario, Pedro Weslley
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (13) : 2950 - 2951
  • [24] Impact of FDG PET on patients with differentiated thyroid cancer who present with elevated thyroglobulin and negative 131I scan
    Schlüter, B
    Bohuslavizki, KH
    Beyer, W
    Plotkin, M
    Buchert, R
    Clausen, M
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (01) : 71 - 76
  • [25] Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in well-differentiated thyroid carcinoma patients with high serum thyroglobulin but negative I-131 whole body scan
    Kunawudhi, Anehisa
    Pak-Art, Rattaplee
    Keelawat, Somboon
    Tepmongkol, Supatporn
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [26] Thyroglobulin doubling time independently predicts 2-[18F]-FDG-PET/CT results in Patients Affected by Differentiated Thyroid Carcinoma with Positive Thyroglobulin Level and Negative 131I Whole Body Scan
    Albano, D.
    Cerudelli, E.
    Gazzilli, M.
    Dondi, F.
    Mazzoletti, A.
    Bellini, P.
    Camoni, L.
    Bertagna, F.
    Giubbini, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S428 - S429
  • [27] Diagnostic value of FDG PET/CT in patients with differentiated thyroid cancer and negative I-131 WBS but high thyroglobulin levels
    Ozdemir, E. Cingi
    Poyraz, N. Yildirim
    Aydin, C.
    Tuzun, D.
    Turkolomez, S.
    Ersoy, R.
    Cakir, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S562 - S562
  • [28] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Vrachimis, Alexis
    Burg, Matthias Christian
    Wenning, Christian
    Allkemper, Thomas
    Weckesser, Matthias
    Schaefers, Michael
    Stegger, Lars
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 (02) : 212 - 220
  • [29] [18F]FDG PET/CT outperforms [18F]FDG PET/MRI in differentiated thyroid cancer
    Alexis Vrachimis
    Matthias Christian Burg
    Christian Wenning
    Thomas Allkemper
    Matthias Weckesser
    Michael Schäfers
    Lars Stegger
    European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43 : 212 - 220
  • [30] Prognostic Significance of FDG PET/CT on the Follow-up of Patients of Differentiated Thyroid Carcinoma With Negative I131 Whole-Body Scan and Elevated Thyroglobulin Levels
    Caobelli, Federico
    Pizzocaro, Claudio
    Guerra, Ugo Paolo
    CLINICAL NUCLEAR MEDICINE, 2013, 38 (03) : 196 - 196